daily

Bybit Brings Back Daily Treasure Hunt With October’s “Hot Token Rush”

DUBAI, UAE, Sept. 26, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is bringing back its fan-favorite…

2 hours ago

NYSE Content Advisory: Pre-Market Update + Wall Street digests August PCE data

NEW YORK, Sept. 26, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

2 hours ago

NYSE Content Advisory: Pre-Market update + Health partners with NBA’s Charlotte Hornets + Proofpoint unveils Satori

NEW YORK, Sept. 24, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

2 days ago

NYSE Content Advisory: Pre-Market update + Mike Waltz, U.S. Ambassador to UN, rings Opening Bell

NEW YORK, Sept. 22, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

4 days ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

5 days ago

China Daily: CAEXPO highlights AI innovations to foster cross-border tech fair

BEIJING, Sept. 19, 2025 /PRNewswire/ -- The 22nd China-ASEAN Expo, held from Wednesday to Sunday in Nanning, the capital of South…

6 days ago

NYSE Content Advisory: Pre-Market Update + Russell 2000 hits first record since 2021

NEW YORK, Sept. 19, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 week ago

NYSE Content Advisory: Pre-Market Update + Fed cuts interest rates by 0.25%

NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 week ago

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease

SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering at Day 84 on the 9mg daily oral…

1 week ago

NYSE Content Advisory: Pre-Market Update + Fed decision & StubHub celebrates IPO

NEW YORK, Sept. 17, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from…

1 week ago